CAH vs UTMD
CAH: Cardinal Health is a healthcare services and logistics company that distributes pharmaceuticals, medical supplies, and healthcare IT solutions to pharmacies, hospitals, and health systems globally. UTMD: Utah Medical Products develops and manufactures specialized, cost-effective medical devices designed to improve patient safety and outcomes in labor, delivery, and neonatal intensive care.
Side-by-side fundamentals
| Metric | CAH | UTMD | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $229.35 | $70.52 | |
| Market cap as of 2026-08-03 | $54.0B | $225M | |
| P/E as of 2026-08-03 | 34.65 | 20.87 | UTMD lower |
| PEG as of 2026-08-03 | 2.06 | n/a | |
| Net margin as of 2026-08-03 | +0.6% | +28.9% | UTMD higher |
| Gross margin as of 2026-08-03 | +3.8% | +57.9% | UTMD higher |
| Operating margin as of 2026-08-03 | +0.9% | +28.8% | UTMD higher |
| ROE as of 2026-08-03 | +37.2% | +9.1% | CAH higher |
| ROA as of 2026-08-03 | +2.8% | +8.9% | UTMD higher |
| Debt / equity as of 2026-08-03 | 5.65 | 0.00 | UTMD lower |
| Revenue growth (YoY) as of 2026-08-03 | +12.9% | -4.4% | CAH higher |
| Revenue CAGR (3y) SEC XBRL | +7.1% | -9.7% | CAH higher |
| Dividend yield as of 2026-08-03 | +0.9% | +1.8% | UTMD higher |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-08-03 | 0.53 | 0.38 | |
| 1-year return as of 2026-07-27 close | +46.0% | +26.8% | CAH higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.